Cargando…
Platelet-to-Lymphocyte Ratio at Admission as a Predictor of In-Hospital and Long-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
BACKGROUND: ST-segment elevation myocardial infarction (STEMI) is the most severe form of acute coronary syndrome (ACS) which is associated with significant adverse outcomes. Platelet-to-lymphocyte ratio (PLR) is a novel inflammatory biomarker that has been used as a predictor of various cardiovascu...
Autores principales: | Willim, Herick Alvenus, Harianto, Joan Carmen, Cipta, Harie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935631/ https://www.ncbi.nlm.nih.gov/pubmed/33738014 http://dx.doi.org/10.14740/cr1219 |
Ejemplares similares
-
Novel predictors of infarct-related artery patency for ST-segment elevation myocardial infarction: Platelet-to-lymphocyte ratio, uric acid, and neutrophil-to-lymphocyte ratio
por: Acet, Halit, et al.
Publicado: (2016) -
The relation of platelet–lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarction
por: Akdag, Serkan, et al.
Publicado: (2016) -
Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention
por: Badran, Hala Mahfouz, et al.
Publicado: (2020) -
Association between the platelet‐lymphocyte ratio and short‐term mortality in patients with non‐ST‐segment elevation myocardial infarction
por: Meng, Zhongyuan, et al.
Publicado: (2021) -
Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction
por: Temiz, Ahmet, et al.
Publicado: (2014)